GlassScriptPhysician profile
Robert J Henke
NPI 1235138975
$5,033.76
in general payments reported to CMS, 2019-2025
40 companies · $644 in 2025
The $644 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $913 · 2021: $669 · 2022: $709 · 2023: $770 · 2024: $723 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $604.72 | 2021-2025 | |
| Lilly USA, LLC | $440.44 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Glaxosmithkline, LLC. | $432.17 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $392.83 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $317.91 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $289.78 | 2019-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $218.92 | 2020-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $198.40 | 2019-2024 | Xarelto |
| Amgen INC. | $191.11 | 2019-2024 | Evenity, Prolia, Otezla |
| Novartis Pharmaceuticals Corporation | $178.82 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $167.85 | 2019-2025 | Eliquis |
| Novo Nordisk INC | $163.44 | 2020-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $140.59 | 2019-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.68 | 2019-2023 | Stiolto Respimat, Jardiance |
| Radius Health, INC. | $112.36 | 2023-2025 | Tymlos |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Henke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.